1. Home
  2. INTT vs GNLX Comparison

INTT vs GNLX Comparison

Compare INTT & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo inTest Corporation

INTT

inTest Corporation

HOLD

Current Price

$11.41

Market Cap

139.2M

Sector

Technology

ML Signal

HOLD

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$2.53

Market Cap

110.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTT
GNLX
Founded
1981
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.2M
110.4M
IPO Year
1997
2022

Fundamental Metrics

Financial Performance
Metric
INTT
GNLX
Price
$11.41
$2.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$13.50
$17.25
AVG Volume (30 Days)
108.2K
297.3K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
9.47
EPS
0.06
N/A
Revenue
$66,801,000.00
$8,000.00
Revenue This Year
$15.82
N/A
Revenue Next Year
$9.10
N/A
P/E Ratio
$193.67
N/A
Revenue Growth
66.06
N/A
52 Week Low
$7.07
$2.29
52 Week High
$20.00
$8.54

Technical Indicators

Market Signals
Indicator
INTT
GNLX
Relative Strength Index (RSI) 39.92 38.62
Support Level $10.32 $2.33
Resistance Level $14.90 $2.97
Average True Range (ATR) 0.51 0.16
MACD 0.08 -0.02
Stochastic Oscillator 41.62 11.61

Price Performance

Historical Comparison
INTT
GNLX

About INTT inTest Corporation

inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Share on Social Networks: